BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38594779)

  • 1. Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma.
    Li Z; Lu W; Yin F; Zeng P; Li H; Huang A
    J Transl Med; 2024 Apr; 22(1):340. PubMed ID: 38594779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircSCUBE3 promoted ferroptosis to inhibit lung adenocarcinoma progression.
    Fu H; Zhao Q
    Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):161-168. PubMed ID: 38430026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
    Gao X; Tang M; Tian S; Li J; Liu W
    Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma.
    Luo S; Luo Y; Wang Z; Yin H; Wu Q; Du X; Xie X
    Cancer Lett; 2024 May; 589():216811. PubMed ID: 38490328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular insights into ferroptosis in lung adenocarcinoma progression and pharmacological compounds for targeted therapy.
    Tian W; Wan X; Tian L; Wu Y; Cui X; Yi J
    J Gene Med; 2024 Jan; 26(1):e3579. PubMed ID: 37581210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.
    Huang L; Zhong L; Cheng R; Chang L; Qin M; Liang H; Liao Z
    Aging (Albany NY); 2023 Sep; 15(18):9676-9694. PubMed ID: 37728413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.
    Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z
    BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of NADK promotes LUAD ferroptosis via NADPH/FSP1 axis.
    Meng X; Peng F; Yu S; Chi X; Wang W; Shao S
    J Cancer Res Clin Oncol; 2024 May; 150(5):228. PubMed ID: 38700533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
    Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X
    Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma.
    Wang Z; Zhang X; Tian X; Yang Y; Ma L; Wang J; Yu Y
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 13. STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis.
    Zhang WD; Hu DM; Shi ZE; Wang QX; Zhang MY; Liu JY; Ji XL; Qu YQ
    Int J Med Sci; 2023; 20(11):1427-1447. PubMed ID: 37790851
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and predictive significance of the ferroptosis-related gene TXNIP in lung adenocarcinoma stem cells based on multi-omics.
    Zheng Y; Yang W; Wu W; Jin F; Lu D; Gao J; Wang S
    Transl Oncol; 2024 Apr; 45():101926. PubMed ID: 38615437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma.
    Liu XS; Zhang Y; Ming X; Hu J; Chen XL; Wang YL; Zhang YH; Gao Y; Pei ZJ
    Aging (Albany NY); 2024 Jan; 16(1):779-798. PubMed ID: 38217547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis 
in Lung Adenocarcinoma Cells].
    Liu L; Guan X; Zhao Y; Wang X; Yin C; Liu Q; Li H
    Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):813-821. PubMed ID: 38061883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4.
    Zhao G; Liang J; Shan G; Gu J; Xu F; Lu C; Ma T; Bi G; Zhan C; Ge D
    Commun Biol; 2023 May; 6(1):570. PubMed ID: 37248295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
    Front Immunol; 2021; 12():724741. PubMed ID: 34335635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.